Join the club for FREE to access the whole archive and other member benefits.
Key points from article :
In a small trial, the drug slowed the progression of the disease and reduced deposits of amyloid plaques, the substances blamed for damaging the brains of people with Alzheimer’s.
The drug, an antibody discovered by screening blood from healthy older people and people whose Alzheimer’s is stable, targets and clears amyloid proteins from the brain.
Click on resource name for more details.
Company specialized in the discovery, development, and delivery of therapies for the treatment of neurological diseases
Vice President, Distinguished Research Fellow, Foundational Neuroscience Center at AbbVie.
